SCHEMBL13147771

SCHEMBL13147771

O=C(Nc1ccccc1N1CCCCC1)c1ccc(-c2ccccc2)o1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.83
▸ MAPT P10636 4/20 0.83
▸ KDM4E B2RXH2 3/20 0.83
▸ LMNA P02545 2/20 0.83
▸ GAA P10253 4/20 0.78
▸ SMN1; SMN2 Q16637 2/20 0.78
▸ CSF1R P07333 7/20 0.70
▸ ALDH1A1 P00352 7/20 0.68
▸ HTT P42858 3/20 0.68
▸ MAPK10 P53779 1/20 0.68
▸ L3MBTL1 Q9Y468 1/20 0.68
▸ NPSR1 Q6W5P4 3/20 0.68
▸ POLB P06746 2/20 0.63
▸ ALOX15 P16050 1/20 0.60
▸ KMT2A Q03164 3/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60
▸ NPC1 O15118 1/20 0.59
▸ TP53 P04637 1/20 0.59
▸ ATM Q13315 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3081171 0.86 CSF1R (0.75) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13148069 0.82 CSF1R (1.00) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13147762 0.82 CSF1R (1.00) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13167004 0.81 ALDH1A1 (1.00) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13147773 0.81 CSF1R (0.67) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13148088 0.81 CSF1R (1.00) HPGDMAPTKDM4ELMNAGAA
SCHEMBL13147776 0.81 CSF1R (1.00) GAACSF1RALDH1A1HTTMAPK10
SCHEMBL13148038 0.79 CSF1R (1.00) LMNAGAACSF1RALDH1A1HTT
SCHEMBL5093277 0.79 CSF1R (1.00) LMNAGAACSF1RALDH1A1HTT
SCHEMBL13147758 0.75 CSF1R (1.00) MAPTKDM4EGAASMN1; SMN2CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 — — US disclosed
WO-2007123516-A1 C-FMS KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-01 — — WO disclosed
Send feedback